Tsokos M, Anders S, Paulsen F
Institute of Legal Medicine, University of Hamburg, Butenfeld 34, 22529 Hamburg, Germany, Germany.
Institute of Pathology, University of Hamburg, Martinistrasse 52, 20246 Hamburg, Germany, Germany.
Virchows Arch. 2002 Feb;440(2):181-186. doi: 10.1007/s004280100488.
A delayed or deficient immunological protection as well as an overstimulation of the mucosal immune system may act as possible additional promoters of sepsis-induced lung injury in patients suffering from a severe septic condition. Lectin-binding patterns in pulmonary tissue samples obtained at autopsy from septic patients and control individuals were studied using 11 carbohydrate-specific lectins (Con A, UEA, GSA I, GSA II, MPA, PNA, Jac, WGA, MAA, LPA, and SNA). There were no differences in the secretory product of serous parts of bronchial glands detectable in the two study groups, whereas lectin binding patterns of alveolar epithelium and mucous parts of subepithelial seromucous glands were different in sepsis cases when compared to controls. Apart from differences in binding sites for alpha-mannose, N-acetyl-neuraminic acid and alpha-(2-6)-galactose (as detected by different expression for Con A, MAA and SNA) in the two study groups, the main finding was that no binding sites for alpha-N-acetyl-galactosamine (as investigated by MPA immunoreactivity) could be detected on alveolar epithelial cells and mucous parts of subepithelial seromucous glands in sepsis cases in contrast to the presence of such binding sites in the control cases. We hypothesize that the finding of an altered secretory product of alveolar epithelial cells and bronchial glands in sepsis may be a result of specific carbohydrate deprivation or consumption, respectively, possibly due to direct bacterial effects or pathogenetic events in response to bacterial toxins during the complex cascade of the host's systemic inflammatory response in sepsis. The altered type of mucus glycoprotein physiologically secreted by alveolar epithelium and mucous parts of subepithelial seromucous glands of the bronchi with subsequent loss of a considerable proportion of protection of the mucosal barrier in sepsis may play an important additional role in the development of sepsis-induced lung injury.
在患有严重脓毒症的患者中,免疫保护延迟或不足以及粘膜免疫系统过度刺激可能是脓毒症诱导的肺损伤的额外潜在促进因素。使用11种碳水化合物特异性凝集素(伴刀豆球蛋白A、荆豆凝集素、大豆凝集素I、大豆凝集素II、麦芽凝集素、花生凝集素、杰克豆凝集素、小麦胚芽凝集素、荆豆凝集素、扁豆凝集素和唾液酸凝集素)研究了脓毒症患者和对照个体尸检时获得的肺组织样本中的凝集素结合模式。在两个研究组中,支气管腺浆液部分的分泌产物没有差异,而与对照组相比,脓毒症病例中肺泡上皮和上皮下浆液粘液腺粘液部分的凝集素结合模式不同。除了两个研究组中α-甘露糖、N-乙酰神经氨酸和α-(2-6)-半乳糖的结合位点存在差异(通过伴刀豆球蛋白A、荆豆凝集素和唾液酸凝集素的不同表达检测)外,主要发现是与对照病例中存在此类结合位点相反,在脓毒症病例的肺泡上皮细胞和上皮下浆液粘液腺的粘液部分未检测到α-N-乙酰半乳糖胺的结合位点(通过麦芽凝集素免疫反应性研究)。我们推测,脓毒症中肺泡上皮细胞和支气管腺分泌产物改变的发现可能分别是特定碳水化合物剥夺或消耗的结果,这可能是由于在脓毒症宿主全身炎症反应的复杂级联过程中,细菌的直接作用或对细菌毒素的致病反应事件。肺泡上皮和支气管上皮下浆液粘液腺粘液部分生理分泌的粘液糖蛋白类型改变,随后脓毒症中粘膜屏障的相当一部分保护作用丧失,这可能在脓毒症诱导的肺损伤发展中起重要的额外作用。